H.C. Wainwright analyst Arthur He CFA reiterated a Buy rating on BioAtla today and set a price target of $25.00. The company’s shares closed last Wednesday at $4.08, close to its 52-week low of $3.40.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioAtla with a $32.25 average price target.
IVERIC bio (ISEE)
In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on IVERIC bio, with a price target of $26.00. The company’s shares closed last Wednesday at $14.95.
Caufield has an average return of
According to TipRanks.com, Caufield is ranked #6627 out of 7897 analysts.
IVERIC bio has an analyst consensus of Strong Buy, with a price target consensus of $25.83, an 80.1% upside from current levels. In a report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a $28.00 price target.
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Acelrx today. The company’s shares closed last Wednesday at $0.22, close to its 52-week low of $0.22.
According to TipRanks.com, Arce is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Acelrx.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BCAB: